Related references
Note: Only part of the references are listed.Id1, but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance
S. Scott Perry et al.
BLOOD (2007)
FOXO3a induces differentiation of Bcr-Abl- transformed cells through transcriptional down-regulation of Id1
Kim U. Birkenkamp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells
Vladimir Jankovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
FOXO transcription factors: key regulators of cell fate
E. W-F. Lam et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization
Frank G. Ruecker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival
S Schnittger et al.
BLOOD (2006)
Gene expression changes associated with progression and response in chronic myeloid leukemia
JP Radich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
AML1-ETO needs a partner - New insights into the pathogenesis of t(8;21) leukemia
F Kuchenbauer et al.
CELL CYCLE (2005)
AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion
JC Mulloy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ABL oncogenes and phosphoinositide 3-kinase:: Mechanism of activation and downstream effectors
NG Kharas et al.
CANCER RESEARCH (2005)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
An activated receptor tyrosine kinase, TEL/PDGFβR cooperates with AML1/ETO to induce acute myeloid leukemia in mice
JL Grisolano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Id proteins in development, cell cycle and cancer
MB Ruzinova et al.
TRENDS IN CELL BIOLOGY (2003)
Id-1 expression promotes cell survival through activation of NF-κB signalling pathway in prostate cancer cells
MT Ling et al.
ONCOGENE (2003)
Chronic myelogenous leukemia molecular signature
MO Nowicki et al.
ONCOGENE (2003)
Induction of C/EBPα activity alters gene expression and differentiation of human CD34+ cells
J Cammenga et al.
BLOOD (2003)
Inducible P27Kip1 expression inhibits proliferation of K562 cells and protects against apoptosis induction by proteasome inhibitors
HCA Drexler et al.
CELL DEATH AND DIFFERENTIATION (2003)
PDGFRA activating mutations in gastrointestinal stromal tumors
MC Heinrich et al.
SCIENCE (2003)
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)
LM Kelly et al.
CANCER CELL (2002)
Role of id family proteins in growth control
Y Yokota et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model
LM Kelly et al.
BLOOD (2002)
Id proteins at the cross-road of development and cancer
A Lasorella et al.
ONCOGENE (2001)
Role of MED1 (MBD4) gene in DNA repair and human cancer
A Bellacosa
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by selective up-regulation of TRAIL-R1
R Di Pietro et al.
BLOOD (2001)
Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia
Q Liu et al.
EMBO JOURNAL (2000)
TEL/PDGFβR fusion protein activates STAT1 and STAT5:: A common mechanism for transformation by tyrosine kinase fusion proteins
AM Wilbanks et al.
EXPERIMENTAL HEMATOLOGY (2000)
Share Paper
